Company / Revenue
Fortress Biotech, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$57.7M
FY2025
5-year range
$45.6M / $84.5M
FY2021-FY2025
Trend
-31.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $76M to $58M over the past 2 years.
Based on SEC 10-K filings.
$58M in FY2025 with a 5-year CAGR of +9.5%.
Declined from $76M to $58M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -5.7%
- 5-Year CAGR
- +9.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +9.5%, indicating consistent growth.
- In FY2025, revenue decreased 31.8% year-over-year.
- Peak revenue was recorded in FY2024.
- Lowest revenue in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $57.7M | -31.8% |
| FY2024 | $84.5M | +11.6% |
| FY2023 | $75.7M | +10.1% |
| FY2022 | $68.8M | +50.9% |
| FY2021 | $45.6M | +24.5% |
| FY2020 | $36.6M | +36.3% |
| FY2019 | $26.9M | +55.9% |
| FY2018 | $17.2M | +1898.3% |
| FY2017 | $863.0K | +0.0% |
| FY2016 | $863.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026